凯发·k8国际(中国)首页登录

KV1

Diagnostyka laboratoryjna

W Mindray wierzymy, ?e ka?de oznaczenie jest wa?ne, bo ka?dy pacjent jest wa?ny. Wi?kszo?? decyzji w zakresie opieki zdrowotnej opiera si? na badaniach laboratoryjnych, wi?c obecnie coraz istotniejsza jest wiarygodno?? wyników.

Firma Mindray daje takie poczucie pewno?ci dzi?ki technologii, innowacjom i d??eniu do rozwijania nauki zwi?zanej z diagnostyk? in vitro. Firma Mindray stworzy?a niezawodne, solidne rozwi?zania, które buduj? zaufanie i zapewniaj? dok?adne wyniki, a jednocze?nie zaspokajaj? potrzeby zwi?zane z wydajno?ci? w laboratoriach na ca?ym ?wiecie.

7
Nowy poziom efektywno?ci i produktywno?ci laboratorium
W coraz bardziej konkurencyjnym ?rodowisku wyzwania stoj?ce przed du?ymi laboratoriami i laboratoriami centralnymi codziennie rosn?. Pomimo ogromnego obci??enia prac? laboratoria musz? szybko generowa? dok?adne wyniki, zwi?ksza? produktywno?? i obni?a? koszty, a jednocze?nie zwi?ksza? swoj? wydajno?? biznesow?. Firma Mindray zapewnia skalowalne, automatyczne rozwi?zania stworzone, by optymalizowa? schematy post?powania i maksymalizowa? wydajno?? laboratorium bez po?wi?cania jako?ci. Dzi?ki niezawodnym rozwi?zaniom firmy Mindray du?e laboratoria mog? odpowiada? na wyzwania dnia dzisiejszego, a tak?e jutra, by uzyska? maksymaln? wydajno??.
1
Lepsza jako?? opieki zdrowotnej dzi?ki wiarygodnym wynikom badań
Dok?adno?? wyników testów jest kluczowa dla jako?ci opieki nad pacjentem. Laboratoria odgrywaj? kluczow? role w zapewnieniu wysokiej jako?ci, op?acalnej opieki klinicznej, dostarczaj?c osobom podejmuj?cym decyzje kliniczne dane naukowe i odpowiednie interpretacje wyników. W firmie Mindray pomagamy laboratoriom osi?ga? wiarygodne wyniki diagnostyczne za pomoc? naszych inteligentnych aparatów, optymalizowanych algorytmów i zaawansowanych technologii, takich jak zamkni?ty system biochemiczny i technologia analizy komórkowej SF Cube.
2
Wspieramy rozwój bran?y dzi?ki dost?pnym zasobom
D???c do wi?kszej dost?pno?ci opieki zdrowotnej, firma Mindray nieustannie wprowadza innowacje, aby dostarcza? niezawodne rozwi?zania i zaawansowane technologie diagnostyczne, które pomog? laboratoriom w ich badaniach naukowych i klinicznych. Dodatkowo firma Mindray pomaga doskonali? umiej?tno?ci i potencja? pracowników laboratoriów poprzez programy szkoleniowe i dost?pne zasoby edukacyjne, a tak?e zach?canie do wymian informacji naukowych za po?rednictwem naszych ogólno?wiatowych platform, takich jak mi?dzy innymi HemaTalk, ChemTalk, LabTalk i ExpertTalk.

Rozwi?zanie dla laboratoriów

  • Du?e laboratoria

    Niezawodne, skalowalne rozwi?zania z dok?adnymi wynikami, aby sprosta? wyzwaniom zwi?zanym z du?ym obci??eniem prac?.

    Czytaj dalej
    8
  • ?rednie laboratoria

    Niezawodne, innowacyjne rozwi?zania stworzone, by zwi?kszy? produktywno?? i dok?adno??.

    Czytaj dalej
    3
  • Ma?e laboratoria

    Niezawodne, stabilne rozwi?zania stworzone, by zwi?kszy? wydajno?? i dok?adno??.

    Czytaj dalej
    5

?ród?a

HemaBook | Hematologia | Badania przesiewowe pod k?tem chorób | HemaBook
Hemabook Chapter 19: Have You Noticed Neutrophil Inclusions in the Thrombocytopenia Smear?
HemaBook | HemaBook
HemaBook Chapter 1 - 18
HemaBook | Hematologia | HemaBook
Hemabook Chapter 18: PLT-H: A new parameter for accurate platelet counting with anti-interference ability
Hematologia | HemaBook | HemaBook
Hemabook Chapter 17: The Clinical Significance of All-in-one CBC Plus ESR Analysis
In the last two chapters, we talked about what ESR is and the applications of ESR, CRP and CBC analysis. ESR is an acute phase reactant and serves as a marker for inflammation. It correlates with disease activity and response to therapy. We understand that single tests are not adequate to confirm any diagnosis, but they do give us important clues.
Hematologia | HemaBook | HemaBook
Hemabook Chapter 16: Where Do You Find Maurer Pigments?
According to the World Health Organization (WHO), there were an estimated 241 million cases of malaria worldwide in 2020, and the estimated number of malaria deaths stood at 627,000 in that year. The African Region was home to 95% of malaria cases and 96% of malaria deaths.
Hematologia | HemaBook | HemaBook
Hemabook Chapter 15: Applications of CBC, ESR and CRP Analysis, Part B
Blood, urine and feces analysis are the three common tests in clinical laboratories. Among them, blood testing is the most important way to keep track of one’s overall physical well-being.
Hematologia | Diagnostyka in vitro | HemaBook | HemaBook | HemaBook
HemaBook Chapter 14: Quick Facts About Erythrocyte Sedimentation Rate (ESR)
The erythrocyte sedimentation rate (ESR), which is determined by the Westergren method, measures how quickly red blood cells (RBCs) settle at the bottom of a blood sample tube in millimeters (mm) in one hour.
Hematologia | Optimal workflow | HemaBook | HemaBook
HemaBook Chapter 13: Capture the Truth About Cell Morphology
Many laboratories are troubled by problems such as lengthy analysis processes and less efficient microscopic examinations due to lacking of experts in cell morphology and inadequate equipment. This makes them hard to reach a 30% overall re-exam rate, a target recommended by the international consensus group for hematology review.
Hematologia | HemaBook | HemaBook
HemaBook Chapter 12: A Clearer Truth? Find it Faster!
In the laboratory, what is the most common reason for you to gather with colleagues to look at and discuss samples or patient results on the screen or in a report?
Hematologia | HemaBook | HemaBook
HemaBook Chapter 11: A 'Sherlock Holmes' Helps You to Capture the Culprit of Diseases
A 43-year-old woman presented with persistent fever for two months. She had visited different hospitals more than three times, but there was no significant improvement in her symptoms. After being admitted to a top-tier hospital in China, she underwent a series of examinations.
Hematologia | HemaBook | HemaBook | COVID-19
Hemabook Chapter 10: How Digital Morphology Systems Help Labs Optimize Their Workflow?
Nowadays, hematology analyzers are used widely in laboratories to automatically count and differentiate blood cells. Nevertheless, blood morphology examination for the presence of abnormal cells is still the ‘gold standard’ in the routine blood count. Microscopic examination is the most valuable procedure in the laboratory, which can suggest some disorders previously identified by the analyzer.
HemaBook | HemaBook | Hematologia | COVID-19
HemaBook Chapter 9: How Does Eosinophil Count Change in COVID-19 Patient
Is prophylactic anticoagulant therapy a common treatment for clinicians to deal with thrombotic events in COVID-19? Is there a connection between the eosinophil count and anticoagulation monitoring in COVID-19 patients?
Hematologia | Diagnostyka in vitro | HemaBook | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | BC-6800Plus | BC-6800 | BC-6000 | COVID-19 | HemaBook
HemaBook Chapter 8: Have You Noticed the Changes of Red Blood Cells in COVID-19?
As of January 26th, 2021, the coronavirus disease 2019 (COVID-19) pandemic has affected over 100 million people worldwide. Vaccination would help improve the situation in future.
Hematologia | Diagnostyka in vitro | HemaBook | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | C3100 | C3510 | COVID-19 | HemaBook
HemaBook Chapter 7: How D-dimer in Coagulation Correlates with COVID-19?
As COVID-19 continues to swipe around the world, rapid diagnosis as well as prognosis and treatment of the COVID-19 patients has become an equally important topic among clinicians. Recently scientists have discovered that COVID-19 has a host cell receptor, Angiotensin Converting Enzyme II or ACE2.
Hematologia | Diagnostyka in vitro | HemaBook | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | HemaBook
HemaBook Chapter 6: Mindray's solution for solving in-vitro PLT aggregation
EDTA-dependent pseudothrombocytopenia (EDTA-PTCP) induced by EDTA anticoagulants is a common laboratory phenomenon. It is caused by in-vitro PLT aggregation and may lead to a low PLT result and, ultimately, misdiagnosis and wrong medical treatment for the patient.
Hematologia | Diagnostyka in vitro | HemaBook | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | CAL 8000(NOWY) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook
HemaBook Chapter 5: How Mindray Counts Low Platelets Correctly
Derived from megakaryocytes, platelets (PLT) are produced and matured in the bone marrow. Besides widely known thrombosis and wound repair, PLT also plays important roles in inflammation, immunity and cancer biology.
Hematologia | Diagnostyka in vitro | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | CAL 8000(NOWY) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | HemaBook
HemaBook Chapter 4: Is Platelet Transfusion Always Required in Thrombocytopenia?
When the platelet (PLT) count is extremely low, is platelet transfusion really required? Let’s analyze the following case, which tells us a different answer.
Hematologia | Diagnostyka in vitro | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | AACC | CAL 8000(NOWY) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | HemaBook
HemaBook Chapter 3: Resolve your concerns about the risk of low-value PLT measurements
When the platelet value is low, patients are at risk of bleeding. Bleeding in vital organs is life-threatening. According to Giuseppe Lippi and other professors, there is no universal agreement on the de?nition of platelet transfusion thresholds.
Hematologia | Diagnostyka in vitro | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | AACC | CAL 8000(NOWY) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6800 | HemaBook | HemaBook
HemaBook Chapter 2: One More Option to Solve EDTA-PTCP?
Ethylenediaminetetraacetic Acid - Pseudothrombocytopenia (EDTA-PTCP) is a laboratory artifact that may lead to an incorrect evaluation and unnecessary treatment of patients.
Hematologia | Diagnostyka in vitro | Diagnostyka laboratoryjna | Diagnostyka laboratoryjna | AACC | CAL 8000(NOWY) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | HemaBook
HemaBook Chapter 1: The Stories of Platelet Clump
Thrombocytopenia is a condition characterized by abnormally low levels of platelets in the blood. However, falsely low platelet counts, or pseudothrombocytopenia (PTCP), though easily unrecognized, are found in clinical cases. It is an in vitro phenomenon caused by platelet clumping that results in reporting of a spuriously low platelet count by automatic hematology analyzers.
Zobacz wi?cej